Caplin Point Board Meeting on Nov 12, 2026 for Financial Results

Caplin Point Laboratories Ltd has announced that its Board of Directors will convene on November 12, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. These results will be presented on both a standalone and consolidated basis. The company is also observing a trading window closure for designated persons from October 1, 2026, to November 14, 2026, in compliance with SEBI regulations.